Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer’s disease is a research paper published in Brain (2021). On theSindex it has a DataRank of 0. It has been cited 95 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Mount Sinai Alzheimer’s Disease Research Center
Grant: P30AG066514
Mount Sinai Alzheimer’s Disease Research Center
Grant: P50AG05138-20
The Rockefeller University
Grant: UL1 TR001866
NIH
Grant: R01 AG063819
NIH
Grant: NIH R01AG064020
Paul B. Beeson Emerging Leaders Career Development Award in Ageing
Grant: K76 AG054772
Karen Strauss Cook Research Scholar Award
Grant: 1 R01 MH075895
NIA NIH HHS
Grant: P50 AG005138
NIA NIH HHS
Grant: R01 AG064020
NIMH NIH HHS
Grant: R01 MH075895
Alzheimer’s Drug Discovery Foundation and Dana Foundation
BrightFocus Foundation
NIH
Bernard L. Schwartz Award for Physician Scientist
Clinical and Translational Science Award
National Center for Advancing Translational Sciences
National Institutes of Health
Alzheimer’s Drug Discovery Foundation
Carolyn and Eugene Mercy Research Support
Robert J. and Claire Pasarow Foundation
Alzheimer’s Association
FWCI
7.11
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals